The Medical University of South Carolina (MUSC) Hollings Cancer Center has announced the installation of a new cancer-fighting technology, TrueBeam STx.
The advanced cancer treatment system provides patients with a nonsurgical, specialised form of treatment that can be completed in five or even fewer outpatient sessions, each lasting 20 minutes or less.
MUSC in partnership with national radiosurgery provider Alliance Oncology has invested in the new technology.
The system will be used to treat patients with stereotactic radiosurgery, a non-invasive method of treating tumours with high-dose radiation appropriately matched to the size and shape of the tumour.
TrueBeam STx helps in reducing radiation exposure to healthy tissue as well as enables doctors to provide customised treatment depending on the nature of cancer.
The system is designed to treat cancerous and noncancerous tumours in the body, including the lung, brain, prostate, spine, liver, pancreas, kidney, bone and eye.
In addition, the system can treat certain blood vessel abnormalities, as well as trigeminal neuralgia, a neuropathic disorder that causes intense facial pain.
MUSCHollings Cancer Center Department of Radiation Oncology chairman Joseph Jenrette III said: "TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities.
"TrueBeam STx can give hope to patients with inoperable or surgically complex tumours, as well as those seeking an alternative to surgery or conventional radiation therapy."
Currently, TrueBeam STx treatments are available at the MUSC Health main campus in downtown Charleston and will be available in Mt. Pleasant in early 2015.
Image: Treatment room at MUSC Health’s Department of Radiation Oncology containing TrueBeam STx technology. Photo: courtesy of PRNewsFoto/MUSC Hollings Cancer Center.